News & Announcements
Hydroxychloroquine is an antimalarial drug also known for its anti-inflammatory and antiviral effects, which have raised the interest of many researchers for its potential use in COVID-19 patients.
Read more about Hydroxychloroquine and QTc: beyond COVID-19Since the outbreak of the Novel Human Coronavirus epidemic, researchers around the world focused their efforts on tackling this global emergency. Research labs are joining forces to find a therapy and a preventive vaccine. Preventive and extraordinary safety measures are crucial to reduce the spread of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) among Health-Care Professionals (HCP). [continue]
The following document is based on the current knowledge of SARS-CoV-2 and the related disease (COVID-19). The Italian Institute of Health (ISS) is monitoring the virus spread throughout the country through daily reports sent by individual regions and regional reference laboratories.
The current SARS-CoV-2 pandemic is still raging in Italy. The country is currently plagued by a huge burden of virus relatedcases and deaths. So far, the disease has highlighted a number of problems, some in common with other Countries and others peculiar to Italy which has suffered from a mortality rate higher than that observed in China and in most Countries in the world.
Multidisciplinary Respiratory Medicine - https://doi.org/10.4081/mrm.2020.672
Read more about SARS-CoV-2 pandemic in Italy: ethical and organizational considerations
On 11 March 2020, the World Health Organization declared a pandemic state, in relation to the spread of the severe acute respiratory syndrome-coronavirus disease- 2, responsible for the coronavirus disease- 2019 (COVID-19). The pandemical blast of COVID-19 uncovered well known weakness of financial chain and put our economic organizations facing off dramatic consequences if new strategies will not be developed to adapt health-care on detailed sub-groups of patients. READ MORE.
https://doi.org/10.4081/gc.2020.9121
Read more about COVID-19 and cardiovascular disease in elderly patients: a challenge in the challenge
Dermatology Reports is the official Journal of ADOI (Associazione Dermatologi-Venereologi Ospedalieri Italiani e della sanità pubblica) publishing scientific papers about skin diseases. Manuscripts dealing with research, biology, epidemiology, clinics of all skin-related diseases are welcome. Dermatology Reports publishes original articles, reviews, brief reports and case reports.
The 58th ADOI National Congress will be held in 29 September - 2nd October 2021.
Read more about The Journal of ADOI (Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanita' pubblica)
After the rapid spread of coronavirus-19 infectious disease (COVID-19) worldwide between February and April 2020, with a total of 5,267,419 confirmed cases and 341,155 deaths as of May 25, 2020, in the last weeks we are observing a decrease in new infections in European countries, and the confirmed cases are not as severe as in the past, so much so that the number of patients transferred to intensive care for the worsening of the systemic and pulmonary disease is dramatically decreasing [...]
Infectious Disease Reports https://doi.org/10.4081/idr.2020.8647
Nicola Petrosillo, National Institute for Infectious Diseases “L. Spallanzani”, IRCCS, Rome, Italy.
Due to COVID-19 outbreak, to lighten the burden of acute and critical care hospitals, some respiratory rehabilitation departments have been used to host patients with COVID-19 in the post-acute phase. This new and unexpected situation required a change of roles and scheduling of the rehabilitation teams. In this manuscript we describe the unexpected and urgent organizational change of the Cardio-Pulmonary Rehabilitation (CPR) service during the COVID-19 emergency in a Northern Italian rehabilitation hospital, focusing on the Respiratory Physiotherapists’ (RPTs) role.
Monaldi Archives for Chest Disease https://doi.org/10.4081/monaldi.2020.1085
Read more about How the COVID-19 infection tsunami revolutionized the work of respiratory physiotherapists: an experience from Northern Italy
Ambroxol (2-amino-3,5-dibromo-N-[trans-4-hydroxycyclohexyl]benzylamine), an over-thecounter product, is a mucoactive agent and has been used widely to treat both acute and chronic respiratory diseases since 1978. This review aims to provide an overview of the clinical evidence available on the use of ambroxol in children with acute and chronic respiratory diseases. Data for this review were obtained from both published and unpublished clinical studies, and real-world evidence studies. Although conducted prior to the introduction of Good Clinical Practice (GCP), these studies, representing almost 1,300 pediatric patients, report strong clinical outcomes following the use of ambroxol in pediatric patients. Furthermore, ....
Multidisciplinary Respiratory Medicine https://doi.org/10.4081/mrm.2020.511
Read more about Ambroxol for the treatment of children with acute and chronic respiratory diseases: an overview of efficacy and safety#COVIDー19 and clinical mimics. Challenges faced while approaching any case of shortness of breath, or other common upper respiratory symptoms during the current #COVID19 #pandemic era.
Monaldi Archives of Chest Disease https://doi.org/10.4081/monaldi.2020.1327
As of 29 April 2020, across the globe, there are 3,216,353 confirmed Coronavirus disease 2019 (COVID-19 disease) with 227,894 deaths. The health care infrastructure of most of the countries is overwhelmed due to the gigantic upsurge of the new cases within a short time period. Most of the beds in the regular wards and critical care units are currently occupied by either people under investigation (PUI) or COVID-19 confirmed cases. We hereby discuss the challenges faced while approaching any case of shortness of breath, or other common upper respiratory symptoms during the current COVID-19 pandemic era.
Read more about COVID-19 and clinical mimics. Correct diagnosis is the key to appropriate therapy
The problems related to the approach to the outbreak of COVID-19 in the world require that all possible effective treatment options be explored. The clinical criterion of the researcher is not to refuse a priori, but to verify and evaluate the proposals that are made. Italian Society of Oxygen Ozone Therapy (SIOOT) proposed to the Italian ISS (Italian Institute of Health) to use oxygen ozone therapy (O2O3) in patients with COVID-19. (...)
https://doi.org/10.4081/ozone.2020.9014
On February 2020, Italy, especially the northern regions, was hit by an epidemic of the new SARS-Cov-2 coronavirus that spread from China between December 2019 and January 2020.
https://doi.org/10.4081/monaldi.2020.1285
Recommendations for COVID-19 Clinical Management from the National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS, Rome, Italy.
Ricerca Psicoanalitica is a member of the Council of Editors of Psychoanalytic Journals and has been for over two decades the journal of relations in psychoanalysis in Italy.
Read more about Launching Ricerca Psicoanalitica
Multidisciplinary Respiratory Medicine is the official journal of the Italian Respiratory Society - Società Italiana di Pneumologia (IRS/SIP).
Read more about Launching Multidisciplinary Respiratory Medicine
PAGEPress has signed the San Francisco Declaration on Research Assessment (DORA).
DORA is a worldwide initiative covering all scholarly disciplines which recognizes the need to improve the ways in which the outputs of scholarly research are evaluated and seeks to develop and promote best practice. To date it has been signed by over 1500 organizations and around 15000 individuals.
Infectious Diseases and Herbal Medicine (IDHM) is an international, Open Access, peer-reviewed, authoritative journal providing basic and applied research.
Beyond Rheumatology is an international, open access, peer-reviewed journal of CReI (Collegio dei Reumatologi Italiani), committed to publishing new discoveries on diagnostic, prognostic, clinical and therapeutic topics about rheumatism and allied conditions.
The Giornale Italiano di Endodonzia was founded in 1987 and is the official journal of the Italian Society of Endodontics (SIE). It is a peer-reviewed journal publishing original articles on clinical research and/or clinical methodology, case reports related to Endodontics. The Journal evaluates also contributes in restorative dentistry, dental traumatology, experimental pathophysiology, pharmacology and microbiology dealing with Endodontics. The Giornale Italiano di Endodonzia is indexed in Scopus, Science Direct, SCImago, Embase, Google Scholar, Academic Search EBSCO, OCLC.
